Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Bio-Techne Corp (TECH : NSDQ)
 
 • Company Description   
Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.

Number of Employees: 3,100

 
 • Price / Volume Information   
Yesterday's Closing Price: $54.41 Daily Weekly Monthly
20 Day Moving Average: 1,833,246 shares
Shares Outstanding: 156.77 (millions)
Market Capitalization: $8,529.71 (millions)
Beta: 1.39
52 Week High: $83.62
52 Week Low: $46.01
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 5.59% 1.63%
12 Week 13.12% -4.85%
Year To Date -24.46% -29.26%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
614 MCKINLEY PLACE NE
-
MINNEAPOLIS,MN 55413
USA
ph: 612-379-8854
fax: 612-656-4400
ir@bio-techne.com http://www.bio-techne.com
 
 • General Corporate Information   
Officers
Kim Kelderman - President; Chief Executive Officer and Director
Robert V. Baumgartner - Chairman of the Board and Director
James Hippel - Executive Vice President and Chief Financial Offic
Shane Bohnen - Senior Vice President; General Counsel & Corp. Sec
Rupert Vessey - Director

Peer Information
Bio-Techne Corp (CORR.)
Bio-Techne Corp (RSPI)
Bio-Techne Corp (CGXP)
Bio-Techne Corp (BGEN)
Bio-Techne Corp (GTBP)
Bio-Techne Corp (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 09073M104
SIC: 2836
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/06/25
Share - Related Items
Shares Outstanding: 156.77
Most Recent Split Date: 11.00 (4.00:1)
Beta: 1.39
Market Capitalization: $8,529.71 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.59%
Current Fiscal Quarter EPS Consensus Estimate: $0.38 Indicated Annual Dividend: $0.32
Current Fiscal Year EPS Consensus Estimate: $1.85 Payout Ratio: 0.19
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: -0.03
Estmated Long-Term EPS Growth Rate: 11.38% Last Dividend Paid: 05/19/2025 - $0.08
Next EPS Report Date: 08/06/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 29.44
Trailing 12 Months: 31.82
PEG Ratio: 2.59
Price Ratios
Price/Book: 4.26
Price/Cash Flow: 23.51
Price / Sales: 7.06
EPS Growth
vs. Year Ago Period: 13.64%
vs. Previous Quarter: 42.86%
Sales Growth
vs. Year Ago Period: 4.20%
vs. Previous Quarter: 6.45%
ROE
06/30/25 - -
03/31/25 - 13.17
12/31/24 - 12.73
ROA
06/30/25 - -
03/31/25 - 10.17
12/31/24 - 9.75
Current Ratio
06/30/25 - -
03/31/25 - 3.71
12/31/24 - 3.94
Quick Ratio
06/30/25 - -
03/31/25 - 2.58
12/31/24 - 2.77
Operating Margin
06/30/25 - -
03/31/25 - 22.62
12/31/24 - 22.08
Net Margin
06/30/25 - -
03/31/25 - 10.89
12/31/24 - 13.22
Pre-Tax Margin
06/30/25 - -
03/31/25 - 13.48
12/31/24 - 15.53
Book Value
06/30/25 - -
03/31/25 - 12.77
12/31/24 - 13.08
Inventory Turnover
06/30/25 - -
03/31/25 - 2.22
12/31/24 - 2.24
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.16
12/31/24 - 0.14
Debt-to-Capital
06/30/25 - -
03/31/25 - 14.05
12/31/24 - 12.61
 

Powered by Zacks Investment Research ©